Search
Menu
InVivoSIM™ Biosimilar Antibodies for Preclinical In Vivo Research
InVivoSIM™ antibodies are research-grade biosimilar antibodies designed for preclinical studies of clinically relevant therapeutic targets. The portfolio includes biosimilar monoclonal antibodies that share the same variable-region amino acid sequence as their corresponding therapeutic antibodies, as well as biosimilar multispecific antibodies for investigating dual-target therapeutic strategies. Together, these reagents support studies of therapeutic mechanisms, target biology, and preclinical efficacy using research-grade biosimilar antibodies.
Every InVivoSIM™ antibody is manufactured for reliable in vivo research, with confirmed binding specificity, ultra-low endotoxin levels (≤0.5 EU/mg), and formulations free of preservatives, stabilizers, and carrier proteins. Each product includes a lot-specific Certificate of Analysis (CoA), providing confidence in product quality and supporting reproducible preclinical research.
Custom biosimilar engineering and manufacturing services are available to support your preclinical research: contractservices@bioxcell.com.
Do you have questions? Visit our FAQs page, contact us by email customerservice@bioxcell.com or call +1-866-787-3444.
View More
Explore Our Antibody Solutions
Discover the difference between antibody lines, customization options, and quality testing.
Access Product Guide